PNC Financial Services Group’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9
Closed -$1K 3940
2020
Q2
$1K Hold
9
﹤0.01% 3839
2020
Q1
$0 Hold
9
﹤0.01% 3915
2019
Q4
$0 Hold
9
﹤0.01% 4004
2019
Q3
$1K Hold
9
﹤0.01% 3914
2019
Q2
$2K Hold
9
﹤0.01% 3855
2019
Q1
$2K Hold
9
﹤0.01% 3863
2018
Q4
$1K Hold
9
﹤0.01% 3935
2018
Q3
$4K Hold
9
﹤0.01% 3844
2018
Q2
$5K Hold
9
﹤0.01% 3830
2018
Q1
$5K Buy
+9
New +$7.8K ﹤0.01% 3884
2017
Q4
Sell
-1
Closed -$2K 4152
2017
Q3
$2K Hold
1
﹤0.01% 3992
2017
Q2
$3K Hold
1
﹤0.01% 3913
2017
Q1
$6K Hold
1
﹤0.01% 3676
2016
Q4
$3K Buy
+1
New +$3.37K ﹤0.01% 3770

Other funds holding CRVO

PNC Financial Services Group's CRVO Position: Q3 2020 in Review

PNC Financial Services Group sold out of CervoMed (CRVO) in Q3 2020, closing a stake of 9 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in CRVO in Q4 2016 and held it in 14 quarters. The position peaked at $6K in Q1 2017. 22 funds tracked by Wall St. Rank hold CRVO as of Q3 2020.

  • PNC Financial Services Group reported no remaining CervoMed position as of Q3 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 9 CervoMed shares in Q3 2020, an estimated $1K.
  • PNC Financial Services Group first reported a position in CervoMed in Q4 2016 and held it in 14 quarters.
  • PNC Financial Services Group's CervoMed position peaked at $6K in Q1 2017.
  • 22 funds tracked by Wall St. Rank held CervoMed as of Q3 2020.

Based on PNC Financial Services Group's 13F filing for Q3 2020, filed 6 Nov 2020.